UroGen Pharma Ltd. - Common Stock (URGN)

CUSIP: M96088105

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock
Shares outstanding
48,457,135
Total 13F shares
13,022,042
Share change
-274,556
Total reported value
$115,449,037
Put/Call ratio
0.29%
Price per share
$8.87
Number of holders
63
Value change
-$2,381,858
Number of buys
22
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP M96088105?
CUSIP M96088105 identifies URGN - UroGen Pharma Ltd. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of URGN - UroGen Pharma Ltd. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Ran Nussbaum
3/4/5
Director
class O/S missing
1,485,168
$26,747,876 21 Oct 2022
MENORA MIVTACHIM HOLDINGS LTD.
13F
Company
6%
2,919,003
$24,286,000 30 Sep 2022
13F
Stonepine Capital Management, LLC
13F
Company
2.3%
1,124,220
$9,354,000 30 Sep 2022
13F
CREDIT SUISSE AG/
13F
Company
2.2%
1,060,000
$8,819,000 30 Sep 2022
13F
Harel Insurance Investments & Financial Services Ltd.
13F
Company
2.1%
1,025,583
$8,533,000 30 Sep 2022
13F
GREAT POINT PARTNERS LLC
13F
Company
1.8%
873,424
$7,267,000 30 Sep 2022
13F
RTW INVESTMENTS, LP
13F
Company
1.8%
857,464
$7,134,000 30 Sep 2022
13F
Migdal Insurance & Financial Holdings Ltd.
13F
Company
1.4%
698,302
$5,810,000 30 Sep 2022
13F
Wildcat Capital Management, LLC
13F
Company
1.1%
533,139
$4,436,000 30 Sep 2022
13F
Clal Insurance Enterprises Holdings Ltd
13F
Company
1.1%
529,388
$4,405,000 30 Sep 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.91%
439,522
$3,657,000 30 Sep 2022
13F
Opaleye Management Inc.
13F
Company
0.82%
397,500
$3,307,000 30 Sep 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.81%
393,138
$3,271,000 30 Sep 2022
13F
Laurion Capital Management LP
13F
Company
0.79%
380,600
$3,167,000 30 Sep 2022
13F
BlackRock Finance, Inc.
13F
Company
0.71%
344,726
$2,868,000 30 Sep 2022
13F
ARK Investment Management LLC
13F
Company
0.58%
281,701
$2,344,000 30 Sep 2022
13F
MEITAV INVESTMENT HOUSE LTD
13F
Company
0.28%
136,835
$1,133,000 30 Sep 2022
13F
Cerity Partners LLC
13F
Company
0.26%
125,226
$1,042,000 30 Sep 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.25%
120,069
$999,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
0.21%
102,582
$853,000 30 Sep 2022
13F
Annandale Capital, LLC
13F
Company
0.17%
84,331
$702,000 30 Sep 2022
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.17%
82,049
$682,000 30 Sep 2022
13F
Ergoteles LLC
13F
Company
0.17%
81,421
$677,000 30 Sep 2022
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.15%
74,431
$619,000 30 Sep 2022
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.12%
59,600
$496,000 30 Sep 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.11%
52,678
$438,000 30 Sep 2022
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.1%
49,222
$410,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
0.09%
45,010
$376,000 30 Sep 2022
13F
UBS Group AG
13F
Company
0.09%
43,589
$363,000 30 Sep 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.09%
43,100
$359,000 30 Sep 2022
13F
BENDER ROBERT & ASSOCIATES
13F
Company
0.08%
41,131
$342,000 30 Sep 2022
13F
Coastal Bridge Advisors, LLC
13F
Company
0.08%
37,000
$308,000 30 Sep 2022
13F
SHIKIAR ASSET MANAGEMENT INC
13F
Company
0.07%
33,250
$277,000 30 Sep 2022
13F
BBR PARTNERS, LLC
13F
Company
0.05%
26,000
$216,000 30 Sep 2022
13F
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd.
13F
Company
0.05%
25,330
$208,000 30 Sep 2022
13F
Palo Alto Investors LP
13F
Company
0.05%
24,500
$204,000 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
23,592
$196,000 30 Sep 2022
13F
XTX Topco Ltd
13F
Company
0.05%
22,544
$188,000 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
0.05%
21,998
$183,000 30 Sep 2022
13F
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD
13F
Company
0.05%
21,823
$179,000 30 Sep 2022
13F
ROYAL BANK OF CANADA
13F
Company
0.03%
14,882
$124,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
14,376
$119,000 30 Sep 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
13,721
$114,000 30 Sep 2022
13F
Qube Research & Technologies Ltd
13F
Company
0.03%
13,289
$111,000 30 Sep 2022
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.02%
11,868
$99,000 30 Sep 2022
13F
Molly Henderson
3/4/5
Chief Financial Officer
mixed-class rows
42,748
mixed-class rows
$94,516 31 Jan 2022
SIMPLEX TRADING, LLC
13F
Company
0.01%
3,845
$31,000 30 Sep 2022
13F
BARCLAYS PLC
13F
Company
0.01%
3,782
$31,000 30 Sep 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
2,378
$20,000 30 Sep 2022
13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
13F
Company
0%
1,400
$12,000 30 Sep 2022
13F

Institutional Holders of UroGen Pharma Ltd. - Common Stock (URGN) as of Q4 2022

As of 31 Dec 2022, UroGen Pharma Ltd. - Common Stock (URGN) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,022,042 shares. The largest 10 holders included MENORA MIVTACHIM HOLDINGS LTD., Stonepine Capital Management, LLC, CREDIT SUISSE AG/, Harel Insurance Investments & Financial Services Ltd., RTW INVESTMENTS, LP, Migdal Insurance & Financial Holdings Ltd., GREAT POINT PARTNERS LLC, Wildcat Capital Management, LLC, Clal Insurance Enterprises Holdings Ltd, and Opaleye Management Inc.. This page lists 63 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
56
Q4 2022 holders
63
Holder diff
7
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .